|
Volumn 143, Issue 6, 2002, Pages 2341-2348
|
Lisofylline, a novel antiinflammatory agent, protects pancreatic β-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE;
ADENOSINE TRIPHOSPHATE;
ANTIINFLAMMATORY AGENT;
CELL NUCLEUS DNA;
CYTOKINE;
GAMMA INTERFERON;
GLUCOSE;
INSULIN;
INTERLEUKIN 1BETA;
LISOFYLLINE;
RECOMBINANT INTERLEUKIN 1BETA;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL CELL;
ARTICLE;
CELL DEATH;
CELL PROTECTION;
CELL VIABILITY;
CONTROLLED STUDY;
DNA STRAND BREAKAGE;
DRUG MECHANISM;
INFLAMMATION;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RELEASE;
MEMBRANE POTENTIAL;
MITOCHONDRIAL MEMBRANE;
MITOCHONDRIAL RESPIRATION;
NONHUMAN;
PANCREAS INSUFFICIENCY;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
RAT;
|
EID: 0036095937
PISSN: 00137227
EISSN: None
Source Type: Journal
DOI: 10.1210/endo.143.6.8841 Document Type: Article |
Times cited : (51)
|
References (38)
|